SCHEMBL9611645

SCHEMBL9611645

O=C(Nc1nc2c(C(=O)Nc3ncc[nH]3)cccc2[nH]1)c1cccc(C2CCCCC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 7/20 0.46
RIPK1 Q13546 1/20 0.45
NPC1 O15118 4/20 0.39
RAB9A P51151 3/20 0.39
PARP1 P09874 6/20 0.38
PARP2 Q9UGN5 4/20 0.38
CDK12 Q9NYV4 3/20 0.38
MAOB P27338 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CDK1 P06493 1/20 0.37
CDK2 P24941 1/20 0.37
CDK5 Q00535 1/20 0.37
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8261440 0.95 RIPK1 (0.40) CNR2RIPK1NPC1RAB9APARP1
SCHEMBL9611635 0.84 RIPK1 (0.43) CNR2RIPK1NPC1RAB9APARP1
SCHEMBL1202466 0.84 RIPK1 (0.40) RIPK1NPC1RAB9APARP1PARP2
SCHEMBL8258916 0.82 MAOB (0.47) NPC1RAB9APARP1MAOBADORA2A
SCHEMBL1201079 0.82 RIPK1 (0.38) RIPK1NPC1RAB9APARP1PARP2
SCHEMBL1202353 0.82 MAOB (0.42) NPC1RAB9APARP1MAOBADORA2A
SCHEMBL1202273 0.81 MAOB (0.45) CNR2NPC1RAB9APARP1PARP2
SCHEMBL1202393 0.81 NPC1 (0.37) CNR2RIPK1NPC1RAB9APARP1
SCHEMBL1202400 0.80 PTGES (0.39) RIPK1NPC1RAB9APARP1PARP2
SCHEMBL12845969 0.80 CNR2 (0.44) CNR2NPC1RAB9APARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2457901-A1 Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors High Point Pharmaceuticals, LLC (US) 2012-05-30 EP disclosed